Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: An NCIC Clinical Trials Group studyC. Cripps, E. A. Eisenhauer, W. Lofters et al.|Annals of Oncology|1999Cited by 100
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancerJean A. Maroun, G. Chiritescu, Derek J. Jonker et al.|European Journal of Cancer|2005Cited by 9